Microbot Medical
MBOT
MBOT
29 hedge funds and large institutions have $2.94M invested in Microbot Medical in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $4.2M → $2.94M (-$1.26M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Holders
29
Holding in Top 10
–
Calls
–
Puts
$4K
Top Buyers
1 | +$48.3K | |
2 | +$31K | |
3 | +$6.28K | |
4 |
UBS Group
Zurich,
Switzerland
|
+$6.2K |
5 |
Morgan Stanley
New York
|
+$5.72K |
Top Sellers
1 | -$187K | |
2 | -$54.6K | |
3 | -$18.9K | |
4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$1.87K |
5 |
Bank of New York Mellon
New York
|
-$312 |